BioSpace News Archive

Biodesix, Inc., a leading data-driven diagnostic solutions company, announced that multiple data presentations will occur at the 2021 annual CHEST virtual conference.

ChromaDex Corp. announced that it will hold a conference call on Wednesday, Nov. 3, 2021 at 4:30 p.m. ET to discuss its financial results for the third quarter ended Sep. 30, 2021.

TCR2 Therapeutics Inc., a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, announced that it will host a virtual R&D Day for analysts and investors at 8:00a.m. ET on Wednesday, October 20, 2021.

Johnson & Johnson will hold a Business Review for the investment community on Thursday, November 18, 2021, in which company leaders will share a detailed review of its Pharmaceuticals business, differentiated strategy and robust pipeline, and long-term growth outlook.

Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for damage or transection to peripheral nerves, today announced that it will report third quarter 2021 financial results on Wednesday, November 3, 2021 after the market closes.

Clearside Biomedical, Inc., a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve vision for people with serious back of the eye diseases, announced that multiple presentations were given at the American Society of Retina Specialists Annual Meeting and at the OIS Retina Summit at ASRS, which took place October 7 - 12, 2021 in San Antonio, TX.

Algernon Pharmaceuticals Inc. is pleased to announce that it has filed a scientific advice meeting request with the United Kingdom (“UK”) Medicines and Healthcare Products Regulatory Agency (“MHRA”) for a Phase 1/2a stroke study with AP-188

OpSens Inc. is pleased to announce the commencement of the human clinical study utilizing the SavvyWire, and successful treatment of the first patients.

Valeo Pharma Inc. announced today that it has been awarded two multi-year listing agreements by two of Canada’s largest Group Purchasing Organizations (“GPO”) for Redesca as well as three additional hospital specialty products.